Log In or Register to Join The Conversation!

This topic has 0 replies, 1 voice, and was last updated 2 years, 6 months ago by Michael Morale.

  • Author
    Posts
    • #12899
      Michael Morale
      Keymaster

      In this episode of the Morale Monologue, I’m going to be giving an update on the results from the recently released Phase 2 clinical trial by Cytokinetics. These results were announced during the 2018 Annual Cure SMA Conference which was held at the Hilton Anatole Hotel in Dallas Texas. In my presentation, I highlight some of these results and give my opinions as to why I believe we have so much to look forward to. Cure SMA hosted a live stream on their Facebook page of the Researcher Q&A session toward the end of this conference. I was allowed to ask a question to the panel of doctors who were representing their respective pharmaceutical companies. My question was posed to the doctors from Cytokinetics and Biogen. I asked if they were planning a combination therapy of their two drugs in the future, since one drug worked on the muscular level and one worked on the cellular level. I cropped this portion of the video and included this into my presentation so everyone could hear my question and their response. I think you’ll be as shocked as I was regarding their response to my question.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2021 All rights reserved.